AtriCure CEO Michael Carrel Acquires 636 Shares via ESPP at $23.78 per Share

This Form 4 filing reports that Michael H. Carrel, President, CEO, and Director of AtriCure, Inc., acquired 636 shares of common stock on June 30, 2026, through the company's 2018 Employee Stock Purchase Plan (ESPP). The shares were purchased at $23.78 per share, representing 85% of the closing price of $27.98 on the acquisition date. Following this transaction, Carrel directly owns 779,134 shares. The filing also discloses indirect holdings through family members: 14,310 shares held by his children, 2,250 shares held by his parents, and 1,000 shares held by his sibling, with Carrel disclaiming beneficial ownership of these family-held shares except for his pecuniary interest. The transaction was executed under the ESPP's standard terms for the period ending June 30, 2026.